Ownership history in BARCLAYS PLC · 17 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 80,784 | +68,084 | +536.1% | 0.00% | $6.6M | $81.88 |
| 2025 Q3 | REDUCED | 12,700 | -79,426 | -86.2% | 0.00% | $755K | $59.43 |
| 2025 Q3 | REDUCED | 92,126 | -35,453 | -27.8% | 0.00% | $5.5M | $59.43 |
| 2025 Q2 | ADDED | 127,579 | +74,740 | +141.4% | 0.00% | $5.2M | $40.51 |
As of 2025 Q4 — sorted by position size